Table 4.
Week 1 | Week 8 | 3-Month follow-up | |
---|---|---|---|
N (%) | N (%) | N (%) | |
BAI | |||
Minimal Anxiety (0–7) | 0 (0) | 5 (16) | 6 (19) |
Mild Anxiety (8–15) | 7 (23) | 6 (19) | 5 (16) |
Moderate Anxiety (16–25) | 3 (10) | 10 (32) | 6 (19) |
Severe Anxiety (26–63) | 21 (68) | 10 (32) | 14 (45) |
BDI-II | |||
Minimal Depression (0–13) | 1 (3) | 14 (45) | 10 (32) |
Mild Depression (14–19) | 2 (6) | 2 (6) | 2 (6) |
Moderate Depression (20–28) | 7 (23) | 4 (13) | 7 (23) |
Severe Depression (29–63) | 21 (68) | 11 (35) | 12 (39) |
WSAS | |||
Subclinical Population (0–9) | 1 (3) | 7 (23) | 6 (19) |
Significant Functional Impairment (10–20) | 2 (6) | 6 (19) | 6 (19) |
Severe Functional Impairment (> 20) | 28 (90) | 18 (58) | 19 (61) |
BAI Beck Anxiety Inventory, BDI-II Beck Depression Inventory-Version ii, WSAS Work and Social Adjustment Scale